Skip to main content
58°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Johnson & Johnson
(NY:
JNJ
)
153.50
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, May 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Johnson & Johnson
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
99
100
Next >
Johnson & Johnson Marks New Era as Global Healthcare Company With Updated Visual Identity
September 14, 2023
From
Johnson & Johnson
Via
Business Wire
3 Warren Buffett Stocks That Are Near Their 52-Week Lows
September 14, 2023
Should you consider loading up on these stocks?
Via
The Motley Fool
Buy the Dip: 3 Healthcare Stocks to Snag Now for Supercharged Gains
September 13, 2023
Unearth the three best healthcare stocks to buy that are poised for long-term growth ahead for savvy investors.
Via
InvestorPlace
Here's My Top Growth Stock to Buy in 2023
September 13, 2023
The growth train is leaving the station and you don't want to miss it. Find out why this stock remains a strong buy even after doubling in 2023.
Via
The Motley Fool
Better Buy: J&J vs. Kenvue
September 13, 2023
You can count on both of these companies for passive income, too.
Via
The Motley Fool
Johnson & Johnson Unusual Options Activity
September 12, 2023
Via
Benzinga
Could This Issue Sink Johnson & Johnson's Stock Price?
September 11, 2023
Don't be too quick to press the sell button.
Via
The Motley Fool
Analyst Ratings for Johnson & Johnson
September 08, 2023
Via
Benzinga
(JNJ) - Analyzing Johnson & Johnson's Short Interest
September 07, 2023
Via
Benzinga
NY Consulting Firm Predicts Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years
September 12, 2023
NY-based strategic consulting firm Research Nester launched global market research for psychedelic substances with projections until 2035.
Via
Benzinga
FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
September 12, 2023
According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in several leading decongestants used by millions of Americans looking for...
Via
Benzinga
Exposures
Product Safety
AstraZeneca's Tagrisso-Chemo Combo Data In Lung Cancer Sets High Bar For Johnson & Johnson's Cancer Drug: Analyst
September 11, 2023
On Sunday night, AstraZeneca Plc (NASDAQ: AZN) presented the Phase 3 FLAURA2 results evaluating Tagrisso plus chemotherapy versus Tagrisso monotherapy as first-line treatment for patients
Via
Benzinga
AI Integration In Biotech & Pharma: Companies Positioned To Benefit
September 11, 2023
The convergence of artificial intelligence (AI) with the biotech and pharmaceutical sectors is ushering in a new era of innovation. AI is catalyzing transformations from drug discovery to patient care....
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Another Arthritis Blockbuster Drug Faces Generic Competition: Novartis' Sandoz Inks Pact With Samsung Bioepis
September 11, 2023
Sandoz, a generic and biosimilar medicines unit of Novartis AG (NYSE: NVS), has
Via
Benzinga
3 Bulletproof Stocks to Buy Before the Next Recession Strikes
September 11, 2023
With these three bulletproof stocks, investors seek refuge in stable and growth-oriented stocks as the specter of economic downturns looms.
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Warren Buffett's Highest-Yielding Stock Isn't Citigroup at 5%. He's Netting Almost 57% Annually From Another Top Holding.
September 11, 2023
Relative to Berkshire's cost basis in the company, this longtime Buffett holding is generating more than 11 times the nominal yield of Citigroup.
Via
The Motley Fool
The 7 Best Warren Buffett Stocks to Buy Now: September 2023
September 10, 2023
With investors not sure of their next move, trying your luck with the best Warren Buffett stocks could be a confidence booster.
Via
InvestorPlace
New to Investing? Here's How You Can Get Started With $500.
September 10, 2023
You don't have to invest a lot to start building a winning portfolio.
Via
The Motley Fool
3 No-Brainer Dividend Stocks to Buy No Matter What the Market Is Doing
September 09, 2023
You'll want to hold on to these players for the long term.
Via
The Motley Fool
The 5 Best Healthcare Stocks to Buy Now: September 2023
September 08, 2023
Unearth the best healthcare stocks offering attractive entry points and opportunities for significant returns. Start investing today!
Via
InvestorPlace
September Rally? 3 Healthcare Stocks to Buy Before Liftoff.
September 08, 2023
The anticipated volume of future healthcare spending makes this a time to look at healthcare stocks to buy for the long term.
Via
InvestorPlace
Dividend Growth Rates and How to Calculate Them
September 08, 2023
Via
MarketBeat
7 Best Blue Chip Stocks to Buy Now
September 08, 2023
Blue-chip stocks are the stocks of well-known, high-quality industry leaders. Learn more about our top picks for the best blue chip stocks to buy now.
Via
MarketBeat
Global Dry Eye Syndrome Treatment Market Expected to Reach $11.26 Billion By 2030
September 08, 2023
EQNX::TICKER_START (NASDAQ:OKYO),(NYSE:ALC),(NYSE:BLCO),(NYSE:JNJ),(OTCQX:RHHBY) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
COVID-19
3 Shaky Stocks to Sell in September Before It’s Too Late
September 08, 2023
Here's a list of stocks to sell that can put your portfolio at potential risk of losses due to legal exposure or poor performance.
Via
InvestorPlace
The 7 Best Dow Stocks to Buy Now: September 2023
September 08, 2023
These are the best Dow stocks to buy because they offer long-term growth, a margin of safety and reliability in an otherwise volatile market.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
3 Stocks Awaiting Winter Winds of Opportunity
September 07, 2023
The change in seasons favors specific stocks like JNJ, GOOS, and MTN, which exhibit growth patterns tied to seasonal changes.
Via
MarketBeat
J&J Spinoff Kenvue is the New Dividend Aristocrat on the Block
September 07, 2023
Newly public company Kenvue, a spinoff from Johnson & Johnson, joins the ranks of dividend aristocrats, offering a 3.57% yield, and 2022 sales of $15 billion.
Via
MarketBeat
Topics
ETFs
1 Brand-New Dividend Stock Income Investors Won't Want to Miss
September 07, 2023
The recently spun-off Kenvue looks to be a high-quality dividend stock.
Via
The Motley Fool
7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth
September 07, 2023
Finding the best pharma stocks to buy takes a little effort, but it will pay of with these seven long-term winners.
Via
InvestorPlace
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.